SPECIAL NOTICE
99 -- Pentostam
- Notice Date
- 8/20/2007
- Notice Type
- Special Notice
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
- ZIP Code
- 21702-5014
- Solicitation Number
- USA-SNOTE-070820-004
- Archive Date
- 11/18/2007
- Description
- The US Army Medical Research Acquisition Activity proposes to award to Glaxo Smith Kline, 980 great West Road, Brentford Middlesex, TW8 9GS, Great Britain for the purchase of FDA Approved Pentostam for the treatment of Leishmaniasis. Pentostam is t he only drug currently available to treat US troops for Leishmaniasis. Competing this requirement will cause delays in the treatment of troop and would also increase the overall cost to the government. This procurement shall be under other than full and open competition procedures in accordance with FAR 6.302. This notice of intent is not a request for competitive quote. Any response to this notice must be submitted in writing to the government and show clear and convincing evidence that another system is capable of meeting the Governments requirements and that competition of the requirement would be advantageous to the government. If no written responses are received at least fifteen (15) days after the publication of this response, the purchase will be awarded without further notice. The Point of Contact (POC) for this action is darrin.flake@us.army.mil.
- Record
- SN01378643-W 20070822/070820221648 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |